Characterization of 9L glioma model of the Wistar rat - PubMed (original) (raw)
Characterization of 9L glioma model of the Wistar rat
Maja Stojiljkovic et al. J Neurooncol. 2003 May.
Abstract
The aim of our study was to develop and characterize solid brain tumors in Wistar rats, which could be used in investigations concerning the molecular mechanisms that lay beneath the genesis of the gliomas as well as in the testing of curative potentials of various therapeutics. The tumors were induced by intracerebral inoculation of 9L glioma cells and characterized by morphometrical, histological and immunohistochemical analysis after 7, 14 and 21 postimplantation days. Immunohistochemical characterization included detection of the nuclear antigene Ki-67 as the proliferative cell marker, GFAP as a tracer of reactive gliosis surrounding the tumor mass, and CD4/CD8 and ED1 antigens, as markers of the immunological response. Our results showed that after 7 days all experimental animals developed solid, well-circumcised tumors, which were clearly separated from the surrounding brain tissue. Tumors showed progressive growth from the 7th to the 21st day despite the observed immunological response starting after 14 days. Histologically tumors were hypercellular with neovascularization and necrosis. These results indicate that reproducible morphometric evaluation can be performed on 9L tumors growing in immunocompetent Wistar rats, enabling its use as an animal tumor model for the evaluation of various therapeutic approaches.
Similar articles
- Morphometrical characterization of two glioma models in the brain of immunocompetent and immunodeficient rats.
Saini M, Bellinzona M, Meyer F, Cali G, Samii M. Saini M, et al. J Neurooncol. 1999 Mar;42(1):59-67. doi: 10.1023/a:1006128825766. J Neurooncol. 1999. PMID: 10360479 - Immunological responsiveness to interleukin-2-producing brain tumors can be restored by concurrent subcutaneous transplantation of the same tumors.
Iwadate Y, Tagawa M, Namba H, Oga M, Kawamura K, Tasaki K, Sakiyama S, Yamaura A. Iwadate Y, et al. Cancer Gene Ther. 2000 Sep;7(9):1263-9. doi: 10.1038/sj.cgt.7700223. Cancer Gene Ther. 2000. PMID: 11023199 - Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
Laterra J, Nam M, Rosen E, Rao JS, Lamszus K, Goldberg ID, Johnston P. Laterra J, et al. Lab Invest. 1997 Apr;76(4):565-77. Lab Invest. 1997. PMID: 9111517 - Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas.
Barth RF. Barth RF. J Neurooncol. 1998 Jan;36(1):91-102. doi: 10.1023/a:1005805203044. J Neurooncol. 1998. PMID: 9525831 Review. - Blood flow and blood-to-tissue transport in 9L gliosarcomas: the role of the brain tumor model in drug delivery research.
Fross RD, Warnke PC, Groothuis DR. Fross RD, et al. J Neurooncol. 1991 Dec;11(3):185-97. doi: 10.1007/BF00165526. J Neurooncol. 1991. PMID: 1823340 Review.
Cited by
- Opening the Blood-Brain Barrier and Improving the Efficacy of Temozolomide Treatments of Glioblastoma Using Pulsed, Focused Ultrasound with a Microbubble Contrast Agent.
Dong Q, He L, Chen L, Deng Q. Dong Q, et al. Biomed Res Int. 2018 Nov 11;2018:6501508. doi: 10.1155/2018/6501508. eCollection 2018. Biomed Res Int. 2018. PMID: 30534564 Free PMC article. - Next-Generation in vivo Modeling of Human Cancers.
Gargiulo G. Gargiulo G. Front Oncol. 2018 Oct 10;8:429. doi: 10.3389/fonc.2018.00429. eCollection 2018. Front Oncol. 2018. PMID: 30364119 Free PMC article. Review. - In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI.
Kadayakkara DK, Janjic JM, Pusateri LK, Young WB, Ahrens ET. Kadayakkara DK, et al. Magn Reson Med. 2010 Nov;64(5):1252-9. doi: 10.1002/mrm.22506. Epub 2010 Sep 21. Magn Reson Med. 2010. PMID: 20860007 Free PMC article. - Longitudinal evaluation of tumor microenvironment in rat focal brainstem glioma using diffusion and perfusion MRI.
Magdoom KN, Delgado F, Bohórquez AC, Brown AC, Carney PR, Rinaldi C, Mareci TH, Ewing JR, Sarntinoranont M. Magdoom KN, et al. J Magn Reson Imaging. 2019 May;49(5):1322-1332. doi: 10.1002/jmri.26315. Epub 2018 Oct 14. J Magn Reson Imaging. 2019. PMID: 30318760 Free PMC article. - Antiangiogenic effect of inhibitors of cytochrome P450 on rats with glioblastoma multiforme.
Zagorac D, Jakovcevic D, Gebremedhin D, Harder DR. Zagorac D, et al. J Cereb Blood Flow Metab. 2008 Aug;28(8):1431-9. doi: 10.1038/jcbfm.2008.31. Epub 2008 Apr 16. J Cereb Blood Flow Metab. 2008. PMID: 18414496 Free PMC article.
References
- J Neurooncol. 1999 Mar;42(1):59-67 - PubMed
- J Neuropathol Exp Neurol. 1993 Nov;52(6):609-18 - PubMed
- J Comput Assist Tomogr. 1980 Jun;4(3):285-90 - PubMed
- J Neurosurg. 1995 Apr;82(4):615-22 - PubMed
- Hum Gene Ther. 1996 Mar 20;7(5):627-35 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous